SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aclaris Therapeutics, Inc. - ACRS

NEW YORK, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aclaris Therapeutics, Inc. (Aclaris or the Company) (NASDAQ: ACRS).